Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q28261358

about

Identification of unique microRNA signature associated with lupus nephritis Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1 Lupus nephritis: the evolving role of novel therapeutics Current perspectives on systems immunology approaches to rheumatic diseases.Applications of systems approaches in the study of rheumatic diseases.Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1.The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Pathogenesis of human systemic lupus erythematosus: recent advances.Interferon-alpha: a therapeutic target in systemic lupus erythematosus Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).Cytokine networks in systemic lupus erythematosus Type I interferon in the pathogenesis of lupus.Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.Interferon alpha in systemic lupus erythematosus Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus.Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases Association of a functional IRF7 variant with systemic lupus erythematosus.Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus.Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus.Association of IRF5 polymorphisms with activation of the interferon alpha pathway Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

P2860

Q21136392-3F46BE63-1A38-4EB4-B250-18AA8AF61506 Q24323367-99486F76-DF8D-49CB-9939-406043C01858 Q24632664-1BB82FAA-E16D-4C42-A082-C62359937F7B Q24655393-BC07A5B9-7421-471D-91DF-3FD232D863F8 Q26998390-68631EEA-1DBB-458A-848C-86FA8BA4CCED Q27687400-6FB487E9-D1A0-43E2-B48E-94CCACB0F0B3 Q27692558-951A4037-8E31-45F0-8FA6-512FD79BC80F Q30873883-5902027D-C715-4157-B488-8BA32A10A71D Q33334070-3FB6A16E-D15B-4D6F-A691-03B419188388 Q33420289-81D393F1-4A74-4F4A-8269-F072B84247B0 Q33532339-F74E13AB-0A38-4F52-8689-74EB1B7EF225 Q33532591-D4EB6C14-FF16-442F-863E-A4053613E8DA Q33588015-F10F2413-7E46-42C9-94A5-58D82E532480 Q33659118-3B1426AF-A195-4A45-A290-20FBE19D3D27 Q33664927-999BF6EA-9A34-4A49-9C51-E3F910878B40 Q33744320-BAEA9F61-F1BD-423A-87DD-38A35C3347FA Q33777950-0F485278-A427-4FBA-8E75-FC1E817079AC Q33801351-010DB8B8-CF77-41D7-AB03-E17C07CE5E86 Q33803103-D4B795F2-E802-45DA-9D41-62C5D98E5FBE Q33852174-9AA54FF2-B5B1-4B1B-9E99-0CF5348A17B7 Q33860888-4D623C6A-EA60-4AE0-B69F-5ACA8C2E82D3 Q33877996-212CBB75-9CF0-42BB-92E6-EC70040F0EA3 Q33915692-B606AFCC-A89F-4E43-9292-220F308942BA Q33923396-FF4C68F6-0365-480A-81F9-F9280ABA0E6D Q33961179-CBCA487C-02B0-40D4-B7E3-D8750395B96A Q34008878-0AD93DEB-DBC8-4470-8185-0D332C4249F9 Q34017633-3086BC8D-1551-464D-9D71-2CF7C822BDB3 Q34027485-9ED41E18-DAA9-4702-A0E7-B36470344D21 Q34115767-BEBC804F-5997-499D-98A9-5C32EA7A8E84 Q34149941-B300097A-F9B7-43A1-9635-E11E76335483 Q34177087-231A6AC9-6C06-4C5F-BD36-1232E18A08DC Q34240254-FD037C0D-53AF-44DE-84DD-F350F23BFBA6 Q34273836-2E961BEC-31A3-407A-965F-03DF88EC40E6 Q34346280-C76D3AAF-B06D-4AD1-BE4B-BD1F1EA8A5E8 Q34713529-5509BD02-9A1D-483F-95FE-C24493D0E7FE Q34984739-B5CF6298-D97B-4BBA-BA88-3503C63C2981 Q35082379-392A1F96-D325-41D6-86AF-4655F51BC5A0 Q35093017-33418CD6-4517-49AF-957B-82E1537C3218 Q35102479-4123044D-DE1E-4F9B-A31E-DFAAB86CD211 Q35147055-95ABDDB3-7334-412B-ADE2-15DDC7D9626C

P2860

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q28261358

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Association of increased inter ...... h systemic lupus erythematosus

@ast

Association of increased inter ...... h systemic lupus erythematosus

@en

Association of increased inter ...... h systemic lupus erythematosus

@nl

type

label

Association of increased inter ...... h systemic lupus erythematosus

@ast

Association of increased inter ...... h systemic lupus erythematosus

@en

Association of increased inter ...... h systemic lupus erythematosus

@nl

prefLabel

Association of increased inter ...... h systemic lupus erythematosus

@ast

Association of increased inter ...... h systemic lupus erythematosus

@en

Association of increased inter ...... h systemic lupus erythematosus

@nl

P1433

Q28261358-E6BAABE9-216F-4DB9-A7AF-BE48128ABEB5

P1476

Q28261358-A94554F5-6642-446A-B7E7-AA8511FA7A04

P2093

Q28261358-0C7B6679-DBB9-4103-89C9-83A37B9DA550

Q28261358-0E4DBEBF-EF67-4099-998B-C079ADD27E9E

Q28261358-161568DC-CD65-4467-B25D-EFDFE6345A4C

Q28261358-269B975A-78E4-433A-9D99-D4939DA1E025

Q28261358-47611DBF-1D9D-47FF-9534-7985E7F07D9E

Q28261358-4E064B04-552F-4D44-BDA3-D5B528514EC1

Q28261358-618775F9-F609-4F19-B19A-4FC771F36710

Q28261358-7459CFDB-FA76-4B20-BAEE-0B000C84CBC1

Q28261358-8B6A17B0-C6BA-4DCE-B689-D6F898C1F1C0

Q28261358-9811C333-91C7-4E13-872C-87AC55F85470

P2860

Q28261358-0495A0E0-1947-4901-8FF1-0E1CFD6F4792

Q28261358-72E3B03E-8011-4387-A74D-05F1567CF601

Q28261358-A86AB573-4266-429B-B582-D1D31D43E12D

Q28261358-C4E8E1C3-173D-4C25-BD4F-DBAB33E212B7

Q28261358-D4A180D3-4529-40F1-846D-4B188E2F783D

P304

Q28261358-79DC1B4A-8C44-40B5-8F64-DEB87FD44CC5

P31

Q28261358-07551C4F-9CFF-4F9D-896B-77B59DB09A6F

P3181

Q28261358-2B977BCA-534D-469A-BC58-C75A6F7921C7

P356

Q28261358-363C546F-74C5-4C8E-88E0-4509A1BA77E6

P407

Q28261358-05B7B2A4-1C93-410B-AE03-84040451915E

P433

Q28261358-0254002D-3FE1-48FE-B378-26C160D71302

P478

Q28261358-6B86ADEE-78E1-421B-9227-1D1504075B50

P50

Q28261358-A48BC5BB-0B09-4ECA-BF28-E5882759AB32

Q28261358-C4CC8B59-A442-4B74-8B3D-DC36D7E607C2

P577

Q28261358-78D97269-1254-4B27-BB1F-AB091A7E1D57

P5875

Q28261358-35ECC956-9D79-4139-811D-E3835FC1B168

P698

Q28261358-15694F9A-C307-474D-BE89-5EE17B1F55B8

P921

Q28261358-94532871-778E-4122-B28D-A8AEDE9DFEB2

P3181

P356

P1433

Arthritis and Rheumatism

P1476

Association of increased inter ...... h systemic lupus erythematosus

@en

P2093

Alan Gorn

http://www.w3.org/2001/XMLSchema#string

Betty P Tsao

http://www.w3.org/2001/XMLSchema#string

Bevra H Hahn

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Ernest Brahn

http://www.w3.org/2001/XMLSchema#string

Grace S Park

http://www.w3.org/2001/XMLSchema#string

Haoling H Weng

http://www.w3.org/2001/XMLSchema#string

Hui Wu

http://www.w3.org/2001/XMLSchema#string

Jennifer M Grossman

http://www.w3.org/2001/XMLSchema#string

Maureen McMahon

http://www.w3.org/2001/XMLSchema#string

P2860

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characteriza

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes.

P304

2951-2962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

101633

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.22044

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

John Fitzgerald

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6841394

http://www.w3.org/2001/XMLSchema#string

P698

16947629

http://www.w3.org/2001/XMLSchema#string

P921